Published on New York State Department of Health, Wadsworth Center (https://www.wadsworth.org)

Rajendra K. Agrawal, PhD

Rajendra K. Agrawal, Ph.D.
Chief, Cellular and Molecular Basis of Diseases
Professor, Department of Biomedical Sciences, University at Albany
PhD, Banaras Hindu University, India
Postdoctoral training: Wadsworth Center

Structure and Function of Cell’s Protein-Synthesizing “Machine”

The Agrawal Laboratory studies the mechanism of protein-synthesis, or gene translation, in humans and in pathogenic bacteria. Ribosomes lie at the center of the protein synthesis machinery in all organisms. While the bacterial ribosomes are the major targets of antibiotics, defects in human mitochondrial ribosomes (mitoribosomes) and translation cause multiple devastating genetic diseases. A deep understanding of ribosome structure and function in humans and pathogenic bacteria is necessary for designing or identifying drug targets so that safer drugs can be designed without affecting the human translational machinery.  The Agrawal Lab’s emphasis is on (i) human mitochondrial, and (ii) mycobacterial ribosomes. His lab uses biochemical, molecular biology, and high-resolution cryo-electron microscopy[1] (cryo-EM) techniques to study these biological systems.  

Studies in the Agrawal Lab allow tracking of conformational transitions undergone by the ribosome and its ligands during protein synthesis. Knowledge of specific conformational transitions is key to understanding the molecular mechanisms of protein synthesis itself, as well as the actions of antibiotics that target the bacterial ribosome or ribosomal ligands to inhibit such transitions. Comparison of results obtained for the bacterial ribosome complexes with those for the host cytosolic and mitochondrial ribosome complexes provides useful information that can lead to identification of new drug targets.  

Visit the Agrawal Laboratory Pages[2]

Research Photo(s)
    HflX (red) disrupts key 23S rRNA helices (green, orange, maroon) within the 50S ribosome (blue hues) to drive drug resistance in mycobacteria (Majumdar et al., 2025).
    HflX (red) disrupts key 23S rRNA helices (green, orange, maroon) within the 50S ribosome (blue hues) to drive drug resistance in mycobacteria (Majumdar et al., 2025).
    HflX (red) reshapes itself to interact with ribosome-bound erythromycin (yellow) in mycobacteria (Majumdar et al., 2025).
    HflX (red) reshapes itself to interact with ribosome-bound erythromycin (yellow) in mycobacteria (Majumdar et al., 2025).
    Structure of a starvation sensing mycobacterial ribosome complex (Li and Majumdar et al., 2023)
    Structure of a starvation sensing mycobacterial ribosome complex (Li and Majumdar et al., 2023)
    Structure of the ribosome from Lyme disease-causing bacteria, Borrelia burgdorferi, with three distinctive ribosomal proteins (Sharma et al., 2023)
    Structure of the ribosome from Lyme disease-causing bacteria, Borrelia burgdorferi, with three distinctive ribosomal proteins (Sharma et al., 2023)
    Structure of the human mitochondrial ribosome recycling complex (Koripella et al., 2021)
    Structure of the human mitochondrial ribosome recycling complex (Koripella et al., 2021)
    Unique interactions between the human mitochondrial ribosomal components and tRNAs (Koripella and Sharma et al., 2020).
    Unique interactions between the human mitochondrial ribosomal components and tRNAs (Koripella and Sharma et al., 2020).